(Q44762880)

6 December 2017

title

T-cell response to adenovirus hexon and DNA-binding protein in mice (English)

1 reference

6 December 2017

1 reference

McKelvey T

1

1 reference

6 December 2017

Tang A

2

1 reference

6 December 2017

Bett AJ

3

1 reference

6 December 2017

Casimiro DR

4

1 reference

6 December 2017

Chastain M

5

1 reference

6 December 2017

publication date

1 May 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

11

1 reference

6 December 2017

issue

9

1 reference

6 December 2017

page(s)

791-796

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302232

6 December 2017

exact match

0 references

cites work

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Immunologic barriers to hepatic adenoviral gene therapy for transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Effective repeat administration with adenovirus vectors to the muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

7 January 2021

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

7 January 2021

Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

7 January 2021

Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

7 January 2021

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

7 January 2021

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

7 January 2021

Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302232

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302232

1 reference

6 December 2017

1 reference